APA
Castañeda S., Llorente I., García-Vicuña R. & González-Álvaro I. (20190306). Anti-citrullinated protein antibodies and bone loss in patients with early arthritis: comment on the article "Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis" by Bugatti et al. : Arthritis research & therapy.
Chicago
Castañeda Santos, Llorente Irene, García-Vicuña Rosario and González-Álvaro Isidoro. 20190306. Anti-citrullinated protein antibodies and bone loss in patients with early arthritis: comment on the article "Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis" by Bugatti et al. : Arthritis research & therapy.
Harvard
Castañeda S., Llorente I., García-Vicuña R. and González-Álvaro I. (20190306). Anti-citrullinated protein antibodies and bone loss in patients with early arthritis: comment on the article "Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis" by Bugatti et al. : Arthritis research & therapy.
MLA
Castañeda Santos, Llorente Irene, García-Vicuña Rosario and González-Álvaro Isidoro. Anti-citrullinated protein antibodies and bone loss in patients with early arthritis: comment on the article "Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis" by Bugatti et al. : Arthritis research & therapy. 20190306.